1 unchanged sentence
Rule 10b5-1 trading arrangements
−Removed: During the three months ended June 30, 2025, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.
+Added: During the three months ended September 30, 2025, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.
Reference is made to the Index to Exhibits included herein.
165 unchanged sentences
and BeiGene Switzerland GmbH, a wholly owned subsidiary of BeiGene, Ltd.
+Added: 1 (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2025 on August 5, 2025 and incorporated herein by reference.)
+Added: 10.19.4* Letter Agreement, dated August 11, 2025, by and between Amgen Inc.
+Added: and BeOne Medicines I GmbH and BeOne Medicines Ltd.
10.20 Guarantee, dated as of October 31, 2019, made by and among BeiGene, Ltd.
34 unchanged sentences
9 to the Collaboration Agreement, dated May 20, 2025, by and between Amgen Inc.
−Removed: and AstraZeneca Collaboration Ventures, LLC (portions of the exhibit have been omitted because they are both (i) not material and (ii) is the type of information that the Company treats as private or confidential.)
+Added: and AstraZeneca Collaboration Ventures, LLC (portions of the exhibit have been omitted because they are both (i) not material and (ii) is the type of information that the Company treats as private or confidential.) (Filed as an exhibit to Form 10-Q for the quarter ended June 30, 2025 on August 5, 2025 and incorporated herein by reference.)
10.23 License and Collaboration Agreement, dated June 1, 2021, by and between Amgen Inc.
27 unchanged sentences
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned, thereunto duly authorized.
−Removed: August 5, 2025 By:
+Added: November 4, 2025 By:
/ S / PETER H.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.